Xianping Shi

发表

Novel use of old drug: Anti-rheumatic agent auranofin overcomes imatinib-resistance of chronic myeloid leukemia cells.

Jinbao Liu, Xuejun Wang, Xin Chen, 2014, Cancer cell & microenvironment.

Cytoplasmic RAP1 mediates cisplatin resistance of non-small cell lung cancer

Jinbao Liu, Lu Xiao, Xuejun Wang, 2017, Cell Death & Disease.

Repurposing an antidandruff agent to treating cancer: zinc pyrithione inhibits tumor growth via targeting proteasome-associated deubiquitinases

D. Zang, Jinbao Liu, Xiaofen Li, 2017, Oncotarget.

Design, synthesis, and biological evaluation of novel water-soluble triptolide derivatives: Antineoplastic activity against imatinib-resistant CML cells bearing T315I mutant Bcr-Abl.

Yanli Jin, Yongcheng Lin, Fang Xu, 2010, Bioorganic & medicinal chemistry.

Triptolide Inhibits Bcr-Abl Transcription and Induces Apoptosis in STI571-resistant Chronic Myelogenous Leukemia Cells Harboring T315I Mutation

Yanli Jin, Chao Cheng, W. Zou, 2009, Clinical Cancer Research.

Triptolide Inhibits Bcr-AblTranscription and Induces Apoptosis in STI 571-resistant Chronic Myelogenous Leukemia Cells

Chao Cheng, W. Zou, Xianping Shi, 2009 .

Activity of triptolide against human mast cells harboring the kinase domain mutant KIT

Yanli Jin, Chao Cheng, Jingxuan Pan, 2009, Cancer science.

Anti-rheumatic agent auranofin induced apoptosis in chronic myeloid leukemia cells resistant to imatinib through both Bcr/Abl-dependent and -independent mechanisms

Quentin Liu, D. Zang, Jinbao Liu, 2014, Oncotarget.

Regulation of melanocyte apoptosis by Stathmin 1 expression.

Jianjun Xiong, Zhenyu Zhu, Jiali Wang, 2008, BMB reports.

Bilirubin neurotoxicity is associated with proteasome inhibition

Jinbao Liu, Y. Nie, P. Zhou, 2017, Cell Death & Disease.

Two clinical drugs deubiquitinase inhibitor auranofin and aldehyde dehydrogenase inhibitor disulfiram trigger synergistic anti-tumor effects in vitro and in vivo

D. Zang, Jinbao Liu, Xiaofen Li, 2015, Oncotarget.

Platinum pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via DUB inhibition-dependent caspase activation and Bcr-Abl downregulation

D. Zang, Jinbao Liu, Hongbiao Huang, 2017, Cell Death & Disease.

Nickel pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via both Bcr/Abl-dependent and Bcr/Abl-independent mechanisms

D. Zang, Jinbao Liu, B. Carter, 2016, Journal of Hematology & Oncology.

2-tert-butyl-1,4-benzoquinone Induces Apoptosis in Chronic MyeloidLeukemia Cells Resistant to Imatinib via Inducing Caspase-Dependent Bcr-Abl Downregulation

Jinbao Liu, B. Carter, Xiaofen Li, 2014 .

2-tert-butyl-1,4-benzoquinone Induces Apoptosis in Chronic Myeloid Leukemia Cells Resistant to Imatinib via Inducing Caspase-Dependent Bcr-

Jinbao Liu, B. Carter, Xiaofen Li, 2014 .

Gambogic Acid Induces Apoptosis in Imatinib-Resistant Chronic Myeloid Leukemia Cells via Inducing Proteasome Inhibition and Caspase-Dependent Bcr-Abl Downregulation

Q. Dou, Jinbao Liu, P. Zhou, 2013, Clinical Cancer Research.

Inhibition of proteasomal deubiquitinases USP14 and UCHL5 overcomes tyrosine kinase inhibitor resistance in chronic myeloid leukaemia

Jinbao Liu, W. Ding, H. Zhou, 2022, Clinical and translational medicine.

Pseudolaric acid B induces mitotic arrest and apoptosis in both imatinib-sensitive and -resistant chronic myeloid leukaemia cells.

Jinbao Liu, Yuening Sun, Xianping Shi, 2020, European journal of pharmacology.

Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth

Ping Zhou, Wenbin Song, Li Xu, 2014, Oncotarget.

Circadian clock cryptochrome proteins regulate autoimmunity

R. Evans, M. Downes, R. Yu, 2017, Proceedings of the National Academy of Sciences.

Cyclin-Dependent Kinase 7/9 Inhibitor SNS-032 Abrogates FIP1-like-1 Platelet-Derived Growth Factor Receptor α and Bcr-Abl Oncogene Addiction in Malignant Hematologic Cells

Yongbin Wu, K. Ding, Bei Jin, 2012, Clinical Cancer Research.

EWS-FLI1 regulates and cooperates with core regulatory circuitry in Ewing sarcoma

Wei Yang, S. Gery, D. Lin, 2020, bioRxiv.

GDP366, a novel small molecule dual inhibitor of survivin and Op18, induces cell growth inhibition, cellular senescence and mitotic catastrophe in human cancer cells

Yanli Jin, Deping Wang, K. Ding, 2010, Cancer biology & therapy.

Super-enhancer-associated MEIS1 promotes transcriptional dysregulation in Ewing sarcoma in co-operation with EWS-FLI1

B. Berman, K. Hu, S. Gery, 2018, Nucleic acids research.

Cancer cell’s neuroendocrine feature can be acquired through cell-cell fusion during cancer-neural stem cell interaction

L. Chung, S. Pandol, H. Zhau, 2020, Scientific Reports.

Gambogic acid induces apoptosis in diffuse large B-cell lymphoma cells via inducing proteasome inhibition

D. Zang, Jinbao Liu, Xiaofen Li, 2015, Scientific Reports.

Piperlongumine overcomes imatinib resistance by inducing proteasome inhibition in chronic myelogenous leukemia cells.

Jinbao Liu, S. Liao, Xin Chen, 2022, Journal of ethnopharmacology.

Cyclin-dependent kinase 7/9 inhibitor SNS-032 induces apoptosis in diffuse large B-cell lymphoma cells

Jinbao Liu, W. Ding, Xianping Shi, 2022, Cancer biology & therapy.

Proteasomal cysteine deubiquitinase inhibitor b-AP15 suppresses migration and induces apoptosis in diffuse large B cell lymphoma

Jinbao Liu, Jinghong Chen, Xianping Shi, 2019, Journal of Experimental & Clinical Cancer Research.

Inactivation of STAT 3 by shRNA Suppresses Cell Growth and Migration in EBV-positive Nasopharyngeal Carcinoma Cells

Guang Yang, Jianjun Xiong, Zhenyu Zhu, 2010 .

Platinum-containing compound platinum pyrithione is stronger and safer than cisplatin in cancer therapy

D. Zang, Jinbao Liu, Zhiming He, 2016, Biochemical pharmacology.

A microRNA-mediated decrease in eukaryotic initiation factor 2α promotes cell survival during PS-341 treatment

D. Zang, Jinbao Liu, Xiaofen Li, 2016, Scientific Reports.

Cancer cell’s neuroendocrine feature can be acquired through cell-cell fusion during cancer-neural stem cell interaction

L. Chung, S. Pandol, H. Zhau, 2020, Scientific Reports.

A novel nickel complex works as a proteasomal deubiquitinase inhibitor for cancer therapy

D. Zang, Q. Dou, Jinbao Liu, 2016, Oncogene.